SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-135602
Filing Date
2017-04-25
Accepted
2017-04-25 07:01:04
Documents
5
Period of Report
2017-06-13
Effectiveness Date
2017-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d282194ddef14a.htm DEF 14A 283507
2 GRAPHIC g282194g42n10.jpg GRAPHIC 21392
3 GRAPHIC g282194g78a96.jpg GRAPHIC 44533
4 GRAPHIC g282194pcpg1.jpg GRAPHIC 202040
5 GRAPHIC g282194pcpg2.jpg GRAPHIC 89714
  Complete submission text file 0001193125-17-135602.txt   769462
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37490 | Film No.: 17779675
SIC: 2834 Pharmaceutical Preparations